Crunching the numbers for VTAK... Refresh in a moment for the full analysis.
Catheter Precision, Inc. (VTAK)
Healthcare
mixed
$1.19
Updated: 2026-04-13
46
TradeApes Score
hold
Financial Strength
40
Weak
Operating Trend
63
Healthy
Valuation
50
Mixed
Capital Allocation
20
Stressed
Risk
50
Mixed
Key Findings
+
Net cash position — more cash on hand than total debt
−
Excessive stock comp — SBC above 15% of revenue, wealth transfer to employees
4 free score cards remaining
TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor.
The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.